Skip to Main Content

Paper Details

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.
Oncotarget
43
2017
CIM, Patients, cancer, cancer biologists, cancers, malignancies, patients, tumor
Author NameAffiliation
Alan H BryceMayo Clinic
Alan H BryceMayo Clinic Cancer Center
Alan H BryceCenter for Individualized Medicine, Mayo Clinic
Alexander Keith StewartMayo Clinic
Alexander Keith StewartCenter for Individualized Medicine, Mayo Clinic
Alexander Keith StewartMayo Clinic Cancer Center
Eric W KleeCenter for Individualized Medicine, Mayo Clinic
Eric W KleeMayo Clinic
Jennifer B McCormickMayo Clinic
Jean-Pierre A KocherCenter for Individualized Medicine, Mayo Clinic
Jean-Pierre A KocherMayo Clinic
Scott A BeckCenter for Individualized Medicine, Mayo Clinic
Gianrico FarrugiaCenter for Individualized Medicine, Mayo Clinic
Gianrico FarrugiaMayo Clinic
Konstantinos N LazaridisCenter for Individualized Medicine, Mayo Clinic
Konstantinos N LazaridisMayo Clinic
Robert W WilliamsCenter for Individualized Medicine, Mayo Clinic
Robert W WilliamsMayo Clinic
Robert W WilliamsMayo Clinic Cancer Center
Robert W WilliamsCenter for Individualized Medicine, Mayo Clinic
Robert W WilliamsMayo Clinic
Robert W WilliamsMayo Clinic Cancer Center
  • 1 - 22

Datasets

Release 1.2